News
News

The latest updates from AFAR.

Board member in the News: Rudy Tanzi in Science Magazine on how exercise generates new neurons and improves cognition in Alzheimer’s mice

Sep 13
2018

Board member in the News: Rudy Tanzi in Science Magazine on how exercise generates new neurons and improves cognition in Alzheimer’s mice

On September 7, 2018, Science Magazine published research co-authored by AFAR expert Rudolph E. Tanzi Ph.D. Dr. Tanzi is an AFAR board member. Read “Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model” here.


View MoreREAD MORE


AFAR Experts in the News: Rozalyn Anderson, Rafael de Cabo, and Yuji Ikeno in Cell Metabolism on fasting and longevity

Sep 11
2018

AFAR Experts in the News: Rozalyn Anderson, Rafael de Cabo, and Yuji Ikeno in Cell Metabolism on fasting and longevity

On September 6, 2018, Cell Metabolism published research co-authored by AFAR experts Rozalyn Anderson, Ph.D., Rafael de Cabo, Ph.D., and Yuji Ikeno, M.D., Ph.D. Dr. Anderson is a 2016 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award winner. Dr. Cabo is a 2014 Vincent Cristofalo Rising Star Award in Aging Research winner. Dr. Ikeno is a 2008 Glenn Foundation for Medical Research Breakthroughs in Gerontology Award winner as well as a 2011-2017 National Scientific Advisory Council member. Read “Daily Fasting Improves Health and Survival in Male Mice Independent of Diet Composition and Calories” here. Learn more about the health benefits…


View MoreREAD MORE


Grantee in the News: Timothy Jarome in The Journal of Neuroscience on how EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation

Sep 11
2018

Grantee in the News: Timothy Jarome in The Journal of Neuroscience on how EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation

On August 29, 2018, The Journal of Neuroscience published research co-authored by AFAR expert Timothy Jarome, Ph.D. Dr. Jarome is a 2016 Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging recipient. Read “EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation” here.


View MoreREAD MORE


Board Member in the News: Nir Barzilai in Medium on the Targeting Aging with Metformin (TAME) Trial

Sep 10
2018

Board Member in the News: Nir Barzilai in Medium on the Targeting Aging with Metformin (TAME) Trial

On September 5, 2018, Medium shared the insights of AFAR expert Nir Barzilai,  M.D. and highlighted the AFAR-managed Targeting Aging with Metformin (TAME) Trial. Dr. Barzilai is AFAR’s Deputy Scientific Director as well as a 1997 Beeson Scholar and 1994 AFAR Research Grant recipient. Read  “The Safe, Boring, and Extremely Cheap Drug That Could Cure Aging” here.


View MoreREAD MORE


Grantee in the News: Pankaj Kapahi’s Research in Cell Metabolism on the role of advanced glycation end products in aging and metabolic diseases

Sep 10
2018

Grantee in the News: Pankaj Kapahi’s Research in Cell Metabolism on the role of advanced glycation end products in aging and metabolic diseases

On September 4, 2018, Cell Metabolism published research co-authored by AFAR expert Pankaj Kapahi, Ph.D. Dr. Kapahi has received multiple AFAR grants including: a 2001 Glenn/AFAR Postdoctoral Fellowship, a 2006 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award, and a 2011 Julie Martin Mid-Career Award in Aging Research. He also served on AFAR’s National Scientific Advisory Council in 2011, 2013, 2014, and 2015. Read, “The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality,” here.


View MoreREAD MORE




BACK TO TOPBACK TO TOP